• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT VASCULAR INC. GRAFTMASTER; CORONARY STENT DELIVERY SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT VASCULAR INC. GRAFTMASTER; CORONARY STENT DELIVERY SYSTEM Back to Search Results
Model Number 1012581-16
Medical Device Problem Codes Off-Label Use (1494); Patient-Device Incompatibility (2682)
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 07/09/2024
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
The device was not returned for evaluation.Production record and corrective and preventative actions (capa) reviews were performed and revealed no indication of a product quality issue.Additionally, a review of the complaint history identified no other incidents from this lot.It was reported the procedure was to treat an arterial extravation in a branch off of the left common femoral artery.The 3.50x16mm graftmaster stent was implanted.A coil was additionally implanted to seal the perforation.It should be noted that the graftmaster rapid exchange (rx) coronary stent graft system, domestic, instructions for use ifu, states: the graftmaster rx is indicated for use in the treatment of free perforations, defined as free contrast extravasation into the pericardium, in native coronary vessels or saphenous vein bypass grafts greater than or equal to 2.75 mm in diameter.In this case, it is unknown if the ifu deviation directly caused or contributed to the reported event.The investigation was unable to determine a conclusive cause for the reported failure to seal; however, the subsequent treatment appears to be related to the operational context of the procedure.There is no indication of a product quality issue with respect to manufacture, design or labeling.
 
Additional Manufacturer Narrative
H6: medical device problem code 1494 clarifier- incorrect anatomy manufacturer's investigation is still pending at this time.Results and conclusions will be provided in the final report.
 
Event or Problem Description
It was reported the procedure was to treat an arterial extravation in a branch off of the left common femoral artery.The 3.50x16mm graftmaster stent was implanted.A coil was additionally implanted to seal the perforation.There were no adverse patient effects and no clinically significant delay in the procedure.No additional information was provided.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
GRAFTMASTER
Common Device Name
CORONARY STENT DELIVERY SYSTEM
Manufacturer (Section D)
ABBOTT VASCULAR INC.
3200 lakeside drive
santa clara CA 95054 2807
Manufacturer (Section G)
ABBOTT VASCULAR, REG # 3005718570 (P099)
cashel road
clonmel tipperary
EI  
Manufacturer Contact
lindsey bell
26531 ynez rd.
temecula, CA 92591-4628
9519143996
MDR Report Key19840597
Report Number2024168-2024-08897
Device Sequence Number7676011
Product Code MAF
UDI-Device Identifier08717648176395
UDI-Public(01)08717648176395(17)250930(10)3102641
Combination Product (Y/N)N
Initial Reporter StateIN
Initial Reporter CountryUS
PMA/510(K) Number
H000001
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2024
Serviced by Third Party (Y/N)N
Reporter Type Manufacturer
Report Source Health Professional,Company Representative
Initial Reporter Occupation Physician
Type of Report Initial,Followup
Report Date (Section B) 10/01/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Expiration Date09/30/2025
Device Model Number1012581-16
Device Catalogue Number1012581-16
Device Lot Number3102641
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Follow-Up
Initial Date Received by Manufacturer 07/10/2024
Supplement Date Received by Manufacturer09/16/2024
Initial Report FDA Received Date07/26/2024
Supplement Report FDA Received Date10/01/2024
Was Device Evaluated by Manufacturer? (Y/N) No
Date Device Manufactured10/26/2023
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Outcome Attributed to Adverse Event Required Intervention;
Patient Age83 YR
Patient SexMale
-
-